SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH M impact

Revive Therapeutics Reports Positive Results

Revive Therapeutics reports positive results from DRDC Bucillamine Nerve-Agent Research Study

RVVRVVTF

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.